Cargando…
Interplay between Transcription Factors and the Epigenome: Insight from the Role of RUNX1 in Leukemia
The genome has the ability to respond in a precise and co-ordinated manner to cellular signals. It achieves this through the concerted actions of transcription factors and the chromatin platform, which are targets of the signaling pathways. Our understanding of the molecular mechanisms through which...
Autores principales: | Brettingham-Moore, Kate H., Taberlay, Phillippa C., Holloway, Adele F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4586508/ https://www.ncbi.nlm.nih.gov/pubmed/26483790 http://dx.doi.org/10.3389/fimmu.2015.00499 |
Ejemplares similares
-
The role of chromatin remodeler SMARCA4/BRG1 in brain cancers: a potential therapeutic target
por: Navickas, Sophie M., et al.
Publicado: (2023) -
GM-CSF promoter chromatin remodelling and gene transcription display distinct signal and transcription factor requirements
por: Brettingham-Moore, Kate H., et al.
Publicado: (2005) -
DNA methylation changes following DNA damage in prostate cancer cells
por: Sutton, Laura P., et al.
Publicado: (2019) -
RUNX1-ETO: Attacking the Epigenome for Genomic Instable Leukemia
por: van der Kouwe, Emiel, et al.
Publicado: (2019) -
Complex Interplay Between MAZR and Runx3 Regulates the Generation of Cytotoxic T Lymphocyte and Memory T Cells
por: Gülich, Alexandra Franziska, et al.
Publicado: (2021)